Although multiple types of immunocytes are involved in T1D development, CD4+ T cells are known as the major culprits given their significant effect on the amplification of autoimmune responses, which rendered them an ideal target for immunotherapy to prevent or attenuate disease progression. Here, CD4 is linked to type 1 diabetes mellitus.